BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19838929)

  • 1. Salvia fruticosa, Salvia officinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway.
    Xavier CP; Lima CF; Fernandes-Ferreira M; Pereira-Wilson C
    Nutr Cancer; 2009; 61(4):564-71. PubMed ID: 19838929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells.
    Xavier CP; Lima CF; Preto A; Seruca R; Fernandes-Ferreira M; Pereira-Wilson C
    Cancer Lett; 2009 Aug; 281(2):162-70. PubMed ID: 19344998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericum androsaemum water extract inhibits proliferation in human colorectal cancer cells through effects on MAP kinases and PI3K/Akt pathway.
    Xavier CP; Lima CF; Fernandes-Ferreira M; Pereira-Wilson C
    Food Funct; 2012 Aug; 3(8):844-52. PubMed ID: 22596086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by Salvia extracts against oxidative and alkylation damage to DNA in human HCT15 and CO115 cells.
    Ramos AA; Pedro D; Collins AR; Pereira-Wilson C
    J Toxicol Environ Health A; 2012; 75(13-15):765-75. PubMed ID: 22788364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daucus carota Pentane-Based Fractions Suppress Proliferation and Induce Apoptosis in Human Colon Adenocarcinoma HT-29 Cells by Inhibiting the MAPK and PI3K Pathways.
    Shebaby WN; Bodman-Smith KB; Mansour A; Mroueh M; Taleb RI; El-Sibai M; Daher CF
    J Med Food; 2015 Jul; 18(7):745-52. PubMed ID: 25599142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.
    Ebi H; Corcoran RB; Singh A; Chen Z; Song Y; Lifshits E; Ryan DP; Meyerhardt JA; Benes C; Settleman J; Wong KK; Cantley LC; Engelman JA
    J Clin Invest; 2011 Nov; 121(11):4311-21. PubMed ID: 21985784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centipedegrass extract induces apoptosis through the activation of caspases and the downregulation of PI3K/Akt and MAPK phosphorylation in leukemia cells.
    Bai HW; Badaboina S; Park CH; Choi BY; Na YH; Chung BY
    Int J Mol Med; 2015 Feb; 35(2):511-8. PubMed ID: 25435190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
    Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
    Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
    Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
    Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells.
    Magesh V; Lee JC; Ahn KS; Lee HJ; Lee HJ; Lee EO; Shim BS; Jung HJ; Kim JS; Kim DK; Choi SH; Ahn KS; Kim SH
    Phytother Res; 2009 Oct; 23(10):1385-91. PubMed ID: 19277950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways.
    Daaboul HE; Daher CF; Bodman-Smith K; Taleb RI; Shebaby WN; Boulos J; Dagher C; Mroueh MA; El-Sibai M
    Chem Biol Interact; 2017 Sep; 275():162-170. PubMed ID: 28782499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z; Jiang C; Ganther H; Lü J
    Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells.
    Cordero-Herrera I; Martín MA; Bravo L; Goya L; Ramos S
    Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.
    Shimizu T; Tolcher AW; Papadopoulos KP; Beeram M; Rasco DW; Smith LS; Gunn S; Smetzer L; Mays TA; Kaiser B; Wick MJ; Alvarez C; Cavazos A; Mangold GL; Patnaik A
    Clin Cancer Res; 2012 Apr; 18(8):2316-25. PubMed ID: 22261800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.